FORTICAL
Dead / Cancelled — Cancelled — Section 8 (as of 20 Mar 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74485072
- Registration number
- 1917114
- Mark type
- Word mark
- Filed
- 01 Feb 1994
- Published for opposition
- 04 Oct 1994
- Registered
- 05 Sept 1995
- Next maintenance due
- 05 Sept 2015
- Attorney of record
- David J. Dykeman
Goods and services
- Class 001 — Chemicals: salmon calcitonin for use for laboratory research purposes and as an ingredient in pharmaceutical preparations
Owner
- ENTERIS BIOPHARMA, INC., BOONTON, NJ, US
- UGP THERAPEUTICS, INC., CHICAGO, IL, US
- Unigene Laboratories, Inc., Fairfield, NJ, US
- Unigene Laboratories, Inc., Fairfield, NJ, US
- Unigene Laboratories, Inc., Fairfield, NJ, US
Prosecution history
- 20 Mar 2026 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 05 Sept 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Aug 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Oct 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 Oct 2015 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 05 Oct 2015 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Oct 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Sept 2015 — TEAS SECTION 8 & 9 RECEIVED
- 11 Jun 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Oct 2005 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 25 Oct 2005 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 13 Oct 2005 — ASSIGNED TO PARALEGAL
- 11 Oct 2005 — ASSIGNED TO PARALEGAL
- 07 Sept 2005 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 07 Sept 2005 — PAPER RECEIVED